Cellutrex LLC – Trademark Portfolio

Entity Type: 16

Cellutrex LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include CELLUTREX and HERO HYDRATE. ENDURE. REPAIR. OPTIMIZE.. The owner is based in Thompson's Station, TN.

2720 Tollie Ln

Thompson's Station, TN 37179

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Cellutrex LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Cellutrex LLC have?

Cellutrex LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.

What trademark classes does Cellutrex LLC file in?

Cellutrex LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Cellutrex LLC's most well-known trademarks?

Cellutrex LLC's registered trademark portfolio includes well-known marks such as CELLUTREX and HERO HYDRATE. ENDURE. REPAIR. OPTIMIZE.. These are among 3 currently registered trademarks in the portfolio.

What is Cellutrex LLC's trademark registration success rate?

Cellutrex LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.